A single cause does not explain amyotrophic lateral sclerosis, and researchers instead point to several overlapping factors. Amyotrophic lateral sclerosis (ALS) is a progressive motor neuron disease that destroys upper and lower motor neurons, and most cases show no clear family history, no single toxin, and no single gene at fault. Doctors diagnose roughly 90 to 95 percent of cases as sporadic, while 5 to 10 percent are familial ALS tied to inherited mutations.
Here’s what the evidence shows about what causes Lou Gehrig’s disease, from the cellular mechanisms that kill neurons to the risk factors that shape your odds.
ALS and Lou Gehrig’s Disease Are the Same Condition
The New York Yankees first baseman received his diagnosis in 1939, ending one of the most famous careers in baseball and giving amyotrophic lateral sclerosis its most recognizable nickname. Gehrig’s farewell at Yankee Stadium drew national attention to a disorder that had been described in medical literature since the 1860s but rarely discussed outside neurology clinics.
ALS damages two kinds of motor neurons at once. Upper motor neurons in the brain send movement signals down the spinal cord, and lower motor neurons in the spinal cord relay those signals to your muscles. When both populations degenerate, the brain loses its ability to command voluntary movement, including walking, speaking, swallowing, and eventually breathing. Stephen Hawking lived with ALS for more than five decades, an outlier course that researchers still study.
How ALS Progresses Once Symptoms Begin
Early signs often show on one side of the body first, usually in a hand, arm, or leg, before spreading. Muscle twitches, cramping, and slurred speech are common first complaints, along with weakness that doesn’t improve with rest. Because ALS spares sensory neurons, people keep their sense of touch, sight, and hearing intact even as voluntary movement fades.
Average life expectancy after diagnosis is roughly two to five years, largely because respiratory muscle failure becomes the limiting factor. More than 30,000 people in the United States live with ALS at any given time, a number that reflects both ongoing incidence and longer survival from better supportive care.
Why ALS Looks Different From Other Neurodegenerative Diseases
ALS is sometimes confused with multiple sclerosis or Parkinson’s, but the underlying damage is distinct. Multiple sclerosis attacks the myelin sheath around nerves, and Parkinson’s destroys dopamine-producing neurons in a specific brain region. ALS targets the motor neuron system itself, which is why weakness and paralysis are the defining symptoms rather than tremor or cognitive decline, although some people with ALS also develop frontotemporal dementia.
The Two Major Forms of ALS Most Cases Fall Into
Doctors split ALS into two broad categories based on whether a clear inherited cause exists. The split matters because it changes how families receive genetic counseling and which clinical trials may be available.
| Feature | Sporadic ALS | Familial ALS |
|---|---|---|
| Share of cases | 90 to 95 percent | 5 to 10 percent |
| Family history | None apparent | Present in at least one relative |
| Typical trigger | Unknown mix of genes and environment | Inherited single-gene mutation |
| Genetic testing value | Limited for relatives | High for at-risk family members |
| Trial eligibility | Broader general criteria | Often gene-specific trial access |
Sporadic ALS Is the Default Diagnosis
About 90 to 95 percent of ALS cases carry no family history, and neurologists label them sporadic by default at the time of diagnosis. That label does not mean nothing caused the disease; it means the trigger has not been identified. Most researchers now believe sporadic ALS arises from a combination of subtle genetic predispositions, environmental exposures, and age-related cellular wear, none of which on its own is enough to explain the disease.
Familial ALS Follows Clear Inheritance Patterns
Familial ALS behaves like a dominantly inherited trait in most families, meaning a child of an affected parent has about a 50 percent chance of carrying the mutation. Penetrance varies, though, and not everyone who inherits the mutation develops symptoms, which complicates risk prediction for healthy relatives.
Genetic Mutations That Drive Familial ALS
More than 40 genes have been linked to ALS, but a handful account for the majority of familial cases. Genetic testing is now standard for anyone with a family history, and results shape both family planning and access to gene-targeted clinical trials.
The Genes Most Often Implicated
- C9orf72 repeat expansion is the single most common genetic cause in people of European ancestry and is also tied to frontotemporal dementia.
- SOD1 mutations were the first ALS genes identified and create a toxic version of an enzyme that normally protects cells from damage.
- TARDBP and FUS mutations disrupt RNA-binding proteins and lead to abnormal protein clumps inside motor neurons.
- TBK1, OPTN, and UBQLN2 each contribute to smaller numbers of familial cases and affect how cells clear damaged proteins.
Why Carriers Don’t Always Get ALS
Reduced penetrance is one of the most puzzling features of familial ALS. A parent can carry a high-risk mutation and remain symptom-free into old age while a sibling develops ALS in their 40s. This pattern suggests that other genetic modifiers, or environmental hits, decide whether the mutation actually causes disease.
That unpredictability raises a harder question: once a mutation is present, what actually kills the motor neurons it touches?
How Motor Neurons Actually Die in ALS
Several overlapping mechanisms drive motor neuron loss, and they reinforce each other in ways that help explain why no single drug has stopped the disease. Researchers from the Mayo Clinic and the ALS Association have outlined four overlapping pathways that converge on the same outcome.
Glutamate Excitotoxicity Overloads the Cell
Glutamate is a normal brain signaling chemical, but in ALS, the system that clears it from the synapse malfunctions. The resulting flood pulls calcium into motor neurons faster than the cells can handle, and the excess calcium triggers enzymes that damage internal structures. The drug riluzole, one of the few approved ALS therapies, works partly by dampening glutamate release.
TDP-43 and Misfolded Proteins Clog the Cell
TDP-43 normally lives in the nucleus and helps process RNA instructions. In roughly 97 percent of ALS cases, TDP-43 leaves the nucleus and forms clumps in the cytoplasm, where it cannot do its job. Protein clearance systems like autophagy and the ubiquitin-proteasome pathway become overwhelmed, and the cell cannot remove the toxic aggregates before they cause harm.
Oxidative Stress and Glial Support Break Down
Motor neurons are unusually large and energy-hungry, which makes them vulnerable to oxidative stress, the cellular damage caused by reactive oxygen molecules. At the same time, the glial cells that normally support and protect motor neurons begin to misbehave, releasing inflammatory signals instead of nourishing the neurons. Together, these changes create a hostile neighborhood that accelerates degeneration.
Because these mechanisms overlap, blocking any one of them often leaves the others active, which is why combination therapies are now a major focus in ALS research.
Established and Suspected ALS Risk Factors
Scientists cannot yet point to a single trigger for the sporadic form, yet at least seven risk factors keep appearing in study after study. Knowing them helps you assess your own profile without falling for speculation.
Demographic and Military Risk
- Age is the strongest non-genetic factor, with risk climbing steadily after the mid-50s and peaking in the late 60s.
- Sex plays a small role, as men develop ALS slightly more often than women before age 65, with the gap narrowing in older groups.
- Military service roughly doubles your odds compared with civilians, regardless of branch or conflict era, according to NINDS data.
Lifestyle and Environmental Suspects
- Head trauma, including repeated concussions, has been linked to ALS in some studies, though the evidence is mixed.
- Smoking appears to modestly raise risk, particularly in women and in people who smoked heavily for decades.
- Heavy metals and pesticides have been investigated as occupational exposures with suggestive but not definitive results.
- Intense physical activity, especially among professional athletes, has been proposed as a trigger, but the data remain contested.
A family history of ALS or frontotemporal dementia raises personal risk, especially when a first-degree relative is affected, because shared variants may not yet be identified.
Even when those risks are stacked together, they still leave most diagnoses without a clean explanation.
Why Most Cases Still Have No Single Identifiable Cause
Sporadic ALS almost certainly reflects an interaction between many small genetic variants rather than one decisive mutation. This multihit model explains why some people with risky exposures never develop ALS while others do, and it frustrates anyone hoping for a single culprit.
Environmental Triggers May Need a Specific Window
Some exposures may need to occur during sensitive biological windows, such as adolescence or early midlife, before they meaningfully raise risk. By the time a person is diagnosed, decades may have passed since the relevant exposure, which makes tracing the cause nearly impossible.
Lifestyle Factors That Don’t Seem to Matter
Diet quality, cholesterol levels, and other factors that matter for heart disease and diabetes have so far shown no consistent link to ALS onset. That absence of evidence has practical value: it tells you there is no known lifestyle change proven to prevent the condition.
Biomarkers Are the Next Frontier
Current research is focused on finding biomarkers, measurable signals in blood, spinal fluid, or imaging, that could one day flag ALS before symptoms appear. Such markers would let high-risk groups enter prevention trials and let doctors start supportive care earlier.
What the Science Cannot Yet Explain About ALS Triggers
There is still no confirmed infectious cause, no single toxin, and no proven lifestyle habit that reliably produces ALS on its own. Cases continue to appear in people with no family history, no military service, and no obvious exposures, which keeps the search for missing triggers active across dozens of labs.
Researchers increasingly view ALS as a spectrum of related motor neuron diseases rather than one disorder with one cause, which explains why gene-targeted trials for SOD1 and C9orf72 are moving faster than broader approaches. Until the full chain from trigger to neuron death is mapped, prevention advice remains limited to general brain and metabolic health, and the best tool you have is understanding the known mechanisms and risk factors well enough to recognize ALS early and seek specialist care.
The Big Picture
ALS has no single known cause, and that is the most important thing to walk away with. What researchers do know is that genetic mutations drive a small share of cases, that overlapping cellular mechanisms kill motor neurons in nearly all of them, and that age, sex, and military service are the clearest risk factors. The fastest path to better outcomes right now is recognizing symptoms early and working with a neurologist who specializes in motor neuron disease.
FAQ
Is Lou Gehrig’s disease genetic?
About 5 to 10 percent of ALS cases run in families through inherited gene mutations, most often in C9orf72 or SOD1. The remaining 90 to 95 percent are sporadic, meaning they occur without a known family history, though subtle genetic risk variants may still contribute.
What are the early signs of ALS?
Muscle weakness in one hand, arm, or leg is typically the first warning sign, often paired with twitching, cramping, slurred speech, or trouble swallowing. Because these complaints overlap with many less serious conditions, a neurologist typically orders electromyography and imaging to rule out mimics before confirming ALS.
Who is most at risk for Lou Gehrig’s disease?
Risk climbs with age and peaks in the late 60s, men are diagnosed slightly more often than women before age 65, and military veterans have roughly twice the civilian rate. A family history of ALS or frontotemporal dementia raises personal risk further, especially when a first-degree relative is affected.
Can Lou Gehrig’s disease be prevented?
No lifestyle change, diet, or supplement has been proven to prevent ALS. Avoiding smoking, protecting your head from repeated trauma, and minimizing exposure to heavy metals and pesticides are reasonable steps, but the strongest prevention tool remains early recognition and prompt specialist evaluation.
What is the life expectancy of someone with ALS?
Roughly two to five years after diagnosis, most patients die from respiratory failure, though individual survival varies widely. Survival varies widely, and a small minority, like Stephen Hawking, live for decades, especially when multidisciplinary care begins early.
What treatments are available for ALS?
There is no cure, but a small number of approved therapies can modestly slow progression and extend survival. Supportive care from a multidisciplinary team, including respiratory, speech, and nutritional specialists, has the largest practical impact on day-to-day quality of life.
